Search
for
Sort by
Research 91–120 of 1000+
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- 5-Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis
- Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- 5α-Reductase inhibitors in androgenetic alopecia
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
- Frontal fibrosing alopecia treatment options
- The risk of dementia with the use of 5 alpha reductase inhibitors
- Hormonal manipulation of benign prostatic hyperplasia
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Frontal fibrosing alopecia: efficacy of treatment modalities
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Algorithmic approach to the treatment of frontal fibrosing alopecia: A systematic review
- Common urologic diseases in older men and their treatment: how they impact fertility
- 5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy)
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- Finasteride versus dutasteride: a real-world economic evaluation.
- Change in hair growth-related gene expression profile in human isolated hair follicles induced by 5-alpha reductase inhibitors – dutasteride and finasteride – in the presence of testosterone
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- 5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction